Cardiovascular magnetic resonance imaging in the assessment of carcinoid heart disease

Carcinoid disease arises from a tow-grade neuroendocrine tumour derived from serotonin-producing enterochromaffin cells. It is the most common tumour affecting the small bowel. The majority of patients who progress to carcinoid syndrome develop cardiac disease selectively involving the right side of the heart, whereas left heart disease is unusual. The most common cause of death is dilatation and dysfunction of the right ventricle. Right ventricular dysfunction is largely secondary to pathological endocardial fibrosis of the tricuspid and pulmonary valves, presenting with regurgitation and stenosis. Average survival falls to only 11 months with the onset of symptoms, but recent evidence suggests that survival can be improved by early surgery in selected individuals. This article reviews the particular rote that cardiovascular magnetic resonance imaging has in the management of carcinoid heart disease. (C) 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.